Pressmeddelande

Calmark relaunches Neo-Bilirubin in Finland

Cision Publicerad: 05 Feb 11:50

Calmark Sweden AB announces today that they have started a relaunch of the product Neo-Bilirubin in Finland together with its distributor Triolab Oy. Triolab has placed an order of less economic value which has been delivered. The product will be exhibited at Lab Quality Days, an exhibition held in Helsinki during this week.

Calmark Sweden Ab already has a distributor agreement with Triolab Oy in Finland. The collaboration has now intensified after Calmark's product Neo-Bilirubin can also be used for capillary sampling. The product will be exhibited at a fair in Helsinki during the week.

"According to the distributor, a number of hospitals and clinics have shown interest in using a near-patient solution for bilirubin tests on newborns," comments CEO Anna Söderlund. "We are very happy about the committed work that Triolab does.”

Bifogade filer

Releasehttps://mb.cision.com/Main/17252/3922548/2582504.pdf

Nyheter om Calmark

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!